Search - tctmd.com

Displaying 21 - 40 of 893

Sort: Relevancy | Date

Presentation TCT 2025

Management of Secondary Mitral Regurgitation: What the Guidelines Say

Presenter: Grant William Reed

October 28, 2025

Presentation TCT 2025

TCT 1187: Perioperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With Concomitant Mitral Regurgitation Revealing Improving Mitral Regurgitation: A Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

Presentation TCT 2025

Interventionalist's Viewpoint

Presenter: Raj Makkar

October 28, 2025

Presentation TCT 2025

Surgeon's Viewpoint

Presenter: Michael J. Mack

October 28, 2025

Presentation TCT 2025

TCT 1194: Feasibility and Safety of Combined Mitral–Tricuspid TEER in Patients with Dual-Valve Regurgitation

Presenter: Dawood Shehzad

October 28, 2025

Presentation TCT 2025

Management of Primary Mitral Regurgitation: What the Guidelines Say

Presenter: Fabien Praz

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Trajectory Guide: A Simple Solution for CIED-Related Tricuspid Regurgitation

Presenter: Vinayak N. Bapat

October 27, 2025

Presentation TCT 2025

The DragonFly T-TEER for Tricuspid Regurgitation: Technology Description and Clinical Results (Case in a Box)

Presenter: Jian'an Wang

October 27, 2025

Presentation TCT 2025

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Presenter: Yan Wang

October 27, 2025

Presentation TCT 2025

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Presenter: Xiaochun Zhang

October 27, 2025

Presentation TCT 2025

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Presenter: Fabien Praz

October 27, 2025

Presentation TCT 2025

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

Presenter: Anson Cheung

October 27, 2025

Presentation TCT 2025

TCT 1474: Navigating Successful MitraClip Placement in a Patient With Severe Mitral Regurgitation and a Chronic Inferior Vena Cava Filter

Presenter: Zahra Manji

October 27, 2025

Presentation TCT 2025

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Presenter: Wenzhi Pan

October 27, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Presenter: Francisco Alexandrino

October 27, 2025

Advertisement

Management of Secondary Mitral Regurgitation: What the Guidelines Say

TCT 1187: Perioperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With Concomitant Mitral Regurgitation Revealing Improving Mitral Regurgitation: A Meta-Analysis

Interventionalist's Viewpoint

Surgeon's Viewpoint

TCT 1194: Feasibility and Safety of Combined Mitral–Tricuspid TEER in Patients with Dual-Valve Regurgitation

Management of Primary Mitral Regurgitation: What the Guidelines Say

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Trajectory Guide: A Simple Solution for CIED-Related Tricuspid Regurgitation

The DragonFly T-TEER for Tricuspid Regurgitation: Technology Description and Clinical Results (Case in a Box)

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

TCT 1474: Navigating Successful MitraClip Placement in a Patient With Severe Mitral Regurgitation and a Chronic Inferior Vena Cava Filter

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content